(Total Views: 485)
Posted On: 08/24/2020 1:35:00 PM
Post# of 208
TSOI an USA company that owns the worldwide patents and rights on QUADRAMUNE and as you know once the QUADRAMUNE clinical trial ends in success in November there will be lot of BIG PHARMA companies that would want to buy/license of QUADRAMUNE pharma version. Also, QUADRAMUNE is much more beyond COVID-19 as it has already been reported that QUADRAMUNE acts as Myleiod Suppressor, and has synergistic effects when used with METFORMIN, HERCEPTIN, RITUXIMAB, ADVAIL, and so on.
Imagine Each of BIG PHARMA buying up the patents of QUADRAMUNE for treatment of Rhematoid Arthritis, Cancers, Depression, Alzheimers, Parkinsons and so on. There are not many OTC companies that become NASDAQ listed company and I honestly feel TSOI is presenting a unique opportunity to all the investors to make 100 bagger in the near future with SOLID SCIENTISTS TEAM.
Imagine Each of BIG PHARMA buying up the patents of QUADRAMUNE for treatment of Rhematoid Arthritis, Cancers, Depression, Alzheimers, Parkinsons and so on. There are not many OTC companies that become NASDAQ listed company and I honestly feel TSOI is presenting a unique opportunity to all the investors to make 100 bagger in the near future with SOLID SCIENTISTS TEAM.
(0)
(0)
